FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070452159> ?p ?o ?g. }

• W2070452159 endingPage "211" @default.
• W2070452159 startingPage "204" @default.
• W2070452159 abstract "To compare the safety and efficacy of sequential intravenous (IV) to oral (PO) moxifloxacin treatment against a standard antimicrobial regimen of IV piperacillin-tazobactam followed by PO amoxicillin-clavulanate for the treatment of adults with complicated intra-abdominal infection (cIAI).cIAIs are commonly due to mixed aerobic and anaerobic bacteria and require both source control and broad-spectrum antibiotic therapy.A prospective, double-blind, randomized, phase III comparative trial. Patients with cIAI were stratified by disease severity (APACHE II score) and randomized to either IV/PO moxifloxacin (400 mg q24 hours) or comparator (IV piperacillin-tazobactam [3.0/0.375 g q6 hours] +/- PO amoxicillin-clavulanate [800 mg/114 mg q12 hours]), each for 5 to 14 days. The primary efficacy variable was clinical cure rate at the test-of-cure visit (days 25-50). Bacteriologic outcomes were also determined.: Of 656 intent-to-treat patients, 379 (58%) were valid to assess efficacy (183 moxifloxacin, 196 comparator). Demographic and baseline medical characteristics were similar between the 2 groups. Clinical cure rates at test-of-cure were 80% (146 of 183) for moxifloxacin versus 78% (153 of 196) for comparator (95% confidence interval, -7.4%, 9.3%). The clinical cure rate at test-of-cure for hospital-acquired cIAI was higher with moxifloxacin (82%, 22 of 27) versus comparator (55%, 17 of 31; P = 0.05); rates were similar for community-acquired infections (80% [124 of 156] versus 82% [136 of 165], respectively). Bacterial eradication rates were 78% (117 of 150) with moxifloxacin versus 77% (126 of 163) in the comparator group (95% confidence interval, -9.9%, 8.7%).Once daily IV/PO moxifloxacin monotherapy was as least as effective as standard IV piperacillin-tazobactam/PO amoxicillin-clavulanate dosed multiple times daily for the treatment of cIAIs." @default.
• W2070452159 created "2016-06-24" @default.
• W2070452159 creator A5029133026 @default.
• W2070452159 creator A5054148328 @default.
• W2070452159 creator A5057503869 @default.
• W2070452159 creator A5071837966 @default.
• W2070452159 creator A5072767452 @default.
• W2070452159 date "2006-08-01" @default.
• W2070452159 modified "2023-10-13" @default.
• W2070452159 title "Randomized Controlled Trial of Moxifloxacin Compared With Piperacillin???Tazobactam and Amoxicillin???Clavulanate for the Treatment of Complicated Intra-abdominal Infections" @default.
• W2070452159 cites W1973763910 @default.
• W2070452159 cites W1980711567 @default.
• W2070452159 cites W2011483204 @default.
• W2070452159 cites W2019235971 @default.
• W2070452159 cites W2027170606 @default.
• W2070452159 cites W2048636010 @default.
• W2070452159 cites W2082810901 @default.
• W2070452159 cites W2085279931 @default.
• W2070452159 cites W2105752232 @default.
• W2070452159 cites W2112824589 @default.
• W2070452159 cites W2112845728 @default.
• W2070452159 cites W2116352191 @default.
• W2070452159 cites W2161452336 @default.
• W2070452159 cites W2244655105 @default.
• W2070452159 cites W79859890 @default.
• W2070452159 cites W9661049 @default.
• W2070452159 doi "https://doi.org/10.1097/01.sla.0000230024.84190.a8" @default.
• W2070452159 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1602153" @default.
• W2070452159 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16858182" @default.
• W2070452159 hasPublicationYear "2006" @default.
• W2070452159 type Work @default.
• W2070452159 sameAs 2070452159 @default.
• W2070452159 citedByCount "114" @default.
• W2070452159 countsByYear W20704521592012 @default.
• W2070452159 countsByYear W20704521592013 @default.
• W2070452159 countsByYear W20704521592014 @default.
• W2070452159 countsByYear W20704521592015 @default.
• W2070452159 countsByYear W20704521592016 @default.
• W2070452159 countsByYear W20704521592017 @default.
• W2070452159 countsByYear W20704521592018 @default.
• W2070452159 countsByYear W20704521592019 @default.
• W2070452159 countsByYear W20704521592020 @default.
• W2070452159 countsByYear W20704521592021 @default.
• W2070452159 countsByYear W20704521592022 @default.
• W2070452159 countsByYear W20704521592023 @default.
• W2070452159 crossrefType "journal-article" @default.
• W2070452159 hasAuthorship W2070452159A5029133026 @default.
• W2070452159 hasAuthorship W2070452159A5054148328 @default.
• W2070452159 hasAuthorship W2070452159A5057503869 @default.
• W2070452159 hasAuthorship W2070452159A5071837966 @default.
• W2070452159 hasAuthorship W2070452159A5072767452 @default.
• W2070452159 hasBestOaLocation W20704521592 @default.
• W2070452159 hasConcept C126322002 @default.
• W2070452159 hasConcept C141071460 @default.
• W2070452159 hasConcept C168563851 @default.
• W2070452159 hasConcept C203092338 @default.
• W2070452159 hasConcept C2777637488 @default.
• W2070452159 hasConcept C2777858937 @default.
• W2070452159 hasConcept C2778193466 @default.
• W2070452159 hasConcept C2778266534 @default.
• W2070452159 hasConcept C2778836808 @default.
• W2070452159 hasConcept C2779454058 @default.
• W2070452159 hasConcept C2779631663 @default.
• W2070452159 hasConcept C2779708577 @default.
• W2070452159 hasConcept C2781413609 @default.
• W2070452159 hasConcept C501593827 @default.
• W2070452159 hasConcept C523546767 @default.
• W2070452159 hasConcept C54355233 @default.
• W2070452159 hasConcept C71924100 @default.
• W2070452159 hasConcept C86803240 @default.
• W2070452159 hasConcept C89423630 @default.
• W2070452159 hasConcept C90924648 @default.
• W2070452159 hasConcept C94665300 @default.
• W2070452159 hasConceptScore W2070452159C126322002 @default.
• W2070452159 hasConceptScore W2070452159C141071460 @default.
• W2070452159 hasConceptScore W2070452159C168563851 @default.
• W2070452159 hasConceptScore W2070452159C203092338 @default.
• W2070452159 hasConceptScore W2070452159C2777637488 @default.
• W2070452159 hasConceptScore W2070452159C2777858937 @default.
• W2070452159 hasConceptScore W2070452159C2778193466 @default.
• W2070452159 hasConceptScore W2070452159C2778266534 @default.
• W2070452159 hasConceptScore W2070452159C2778836808 @default.
• W2070452159 hasConceptScore W2070452159C2779454058 @default.
• W2070452159 hasConceptScore W2070452159C2779631663 @default.
• W2070452159 hasConceptScore W2070452159C2779708577 @default.
• W2070452159 hasConceptScore W2070452159C2781413609 @default.
• W2070452159 hasConceptScore W2070452159C501593827 @default.
• W2070452159 hasConceptScore W2070452159C523546767 @default.
• W2070452159 hasConceptScore W2070452159C54355233 @default.
• W2070452159 hasConceptScore W2070452159C71924100 @default.
• W2070452159 hasConceptScore W2070452159C86803240 @default.
• W2070452159 hasConceptScore W2070452159C89423630 @default.
• W2070452159 hasConceptScore W2070452159C90924648 @default.
• W2070452159 hasConceptScore W2070452159C94665300 @default.
• W2070452159 hasIssue "2" @default.
• W2070452159 hasLocation W20704521591 @default.
• W2070452159 hasLocation W20704521592 @default.
• W2070452159 hasLocation W20704521593 @default.

• next